Clinical Trial Update: MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating MTBVAC in adults with and without latent TB infection in South Africa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MTBVAC

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED